Risk-Based Export Screening is a systematic method for evaluating and prioritizing drug export transactions according to their likelihood and potential impact of non-compliance with regulatory controls, distinguishing it from rule-based or random screening approaches by its reliance on dynamic risk indicators and analytical assessment.